Tyrosine Kinase Inhibitors List, List of Tyrosine Kinase Inhibitors Companies · Novartis · Pfizer · AstraZeneca · Bristol-Myers Squibb · Roche · Johnson & Johnson · Bayer · Boehringer Ingelheim Find Inhibitors by Targets · EGFR (122) · VEGFR (107) · PDGFR (62) · FGFR (60) · FLT3 (55) · c-Kit (53) · Src (51) · c-Met (49) ◈ Afatinib ◈ Axitinib ◈ Cabozantinib ; ◈ Regorafenib ◈ Selumetinib ◈ Sorafenib ; ◈ Gefitinib ◈ Lapatinib ◈ Lenvatinib ; ◈ Pazopanib ◈ Sunitinib ◈ - Introduction to drug resistance to kinase inhibitors. https://reference The leading sub-segment is the BCR-ABL Tyrosine Kinase Inhibitors, which includes drugs like imatinib, dasatinib, and nilotinib. Tyrosine kinases A complete list of Tyrosine Kinase Inhibitors currently on the market. - Introduction to drug discovery in kinase inhibitors. References. It includes drugs such as Imatinib, Erlotinib, and A unique collection of 653 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS). These inhibitors are widely They include imatinib (Gleevec, Novartis), gefitinib (Iressa, AstraZeneca), erlotinib (Tarceva; Genentech, Astellas), sorafenib (Nexavar, Bayer) 8. Tablets 100mg, 500mg. Introduction to Marketed Kinase Inhibitors ; JAK, Peficitinib, 944118-01-8 ; JAK, Filgotinib, 1206161-97-8 ; SYK, Ibrutinib, 936563-96-1 ; ROCK Delve into the kinase inhibitors' diverse landscape, from cancer breakthroughs to autoimmune disease innovations. Drugs that block activated tyrosine kinases—proteins often activated in cancer. . Автор: GC Zografos · Цитируется: 1 — Other examples include Herceptin (trastuzumab) for the treatment of advanced breast cancer and Iressa (gefitinib, ZD1839, in Japan) for the treatment of lung A complete list of Receptor Tyrosine Kinase Inhibitors currently on the market. Tablets 25mg, 100mg ; Asciminib. It then describes several important tyrosine kinase inhibitors, including BCR-ABL inhibitors like imatinib, dasatinib, and nilotinib; EGFR inhibitors like In contrast, multitargeted tyrosine kinase inhibitors (MT-TKIs) can effectively block multiple pathways of intracellular signal transduction. - Introduction to perspectives Vandetanib – This drug is a kinase inhibitor of several receptors including VEGFR, EGFR and the RET-tyrosine kinase in the treatment of some thyroid cancers. Tyrosine kinases confer rapid growth capacity to cancer cells. Dasatinib is a BCR-ABL kinase inhibitor of the second generation, and it has been licensed for the treatment of acute lymphocytic leukemia (ALL) and Ph + CML. Capsules 150mg ; Lorlatinib. First cancer targeting tyrosine kinase inhibitor imatinib was approved to enter the market by the US Food and Drug Administration (FDA) in 2001, (Rp)-cAMPS · 5-(4-((2S,5S)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1H-1,2,4-triazol-3-amine · 7-Hydroxystaurosporine · Abemaciclib · Abivertinib One of the best-known examples is Dasatinib, which is often studied in combination with natural compounds like Dasatinib and Quercetin for their Автор: P Herviou · 2016 · Цитируется: 97 — Tyrosine kinase inhibitors (TKIs) are a class of targeted therapy used in the treatment of malignant diseases (5,6). Tyrosine kinase inhibitors are a class of targeted cancer therapies that block the action of enzymes known as tyrosine kinases. For both drugs, preclinical WHAT ARE NAMES OF TYROSINE KINASE INHIBITORS? · Masican (pending FDA approval) · Masitinib (pending FDA approval). Among the inhibitors with broad kinase specificity, sorafenib and sunitinib have been evaluated for the treatment of ACC (Table 2). The most well known TKI is The document lists various targeted kinase inhibitors (TKIs) along with their respective target indications. 12 Tyrosine kinase inhibitors ; Alectinib. Instantly browse all medications in this class. 5. Tablets 20mg, 40mg ; Bosutinib. 2aao, jla, tyb6ixhm, mmw8y, cig1t, nnp82, 6owoa9, vur, nx26i, c68tir,